Shanghai Pharmaceuticals Holding Co., Ltd

SHSE:601607 Rapporto sulle azioni

Cap. di mercato: CN¥64.7b

Shanghai Pharmaceuticals Holding Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Shanghai Pharmaceuticals Holding has a total shareholder equity of CN¥83.2B and total debt of CN¥48.4B, which brings its debt-to-equity ratio to 58.2%. Its total assets and total liabilities are CN¥223.7B and CN¥140.6B respectively. Shanghai Pharmaceuticals Holding's EBIT is CN¥8.6B making its interest coverage ratio -346. It has cash and short-term investments of CN¥42.4B.

Informazioni chiave

58.2%

Rapporto debito/patrimonio netto

CN¥48.42b

Debito

Indice di copertura degli interessi-346x
ContantiCN¥42.39b
Patrimonio nettoCN¥83.16b
Totale passivitàCN¥140.58b
Totale attivitàCN¥223.74b

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Not Many Are Piling Into Shanghai Pharmaceuticals Holding Co., Ltd (SHSE:601607) Just Yet

Sep 30
Not Many Are Piling Into Shanghai Pharmaceuticals Holding Co., Ltd (SHSE:601607) Just Yet

Shanghai Pharmaceuticals Holding (SHSE:601607) Has Some Way To Go To Become A Multi-Bagger

Aug 09
Shanghai Pharmaceuticals Holding (SHSE:601607) Has Some Way To Go To Become A Multi-Bagger

Shanghai Pharmaceuticals Holding's (SHSE:601607) Dividend Is Being Reduced To CN¥0.41

Jul 18
Shanghai Pharmaceuticals Holding's (SHSE:601607) Dividend Is Being Reduced To CN¥0.41

Shanghai Pharmaceuticals Holding (SHSE:601607) Has A Somewhat Strained Balance Sheet

Jun 25
Shanghai Pharmaceuticals Holding (SHSE:601607) Has A Somewhat Strained Balance Sheet

Shanghai Pharmaceuticals Holding Co., Ltd's (SHSE:601607) Earnings Are Not Doing Enough For Some Investors

May 21
Shanghai Pharmaceuticals Holding Co., Ltd's (SHSE:601607) Earnings Are Not Doing Enough For Some Investors

Earnings Miss: Shanghai Pharmaceuticals Holding Co., Ltd Missed EPS By 30% And Analysts Are Revising Their Forecasts

Apr 01
Earnings Miss: Shanghai Pharmaceuticals Holding Co., Ltd Missed EPS By 30% And Analysts Are Revising Their Forecasts

Returns At Shanghai Pharmaceuticals Holding (SHSE:601607) Appear To Be Weighed Down

Mar 16
Returns At Shanghai Pharmaceuticals Holding (SHSE:601607) Appear To Be Weighed Down

We Think Shanghai Pharmaceuticals Holding (SHSE:601607) Can Stay On Top Of Its Debt

Feb 29
We Think Shanghai Pharmaceuticals Holding (SHSE:601607) Can Stay On Top Of Its Debt

Analisi della posizione finanziaria

Passività a breve termine: 601607's short term assets (CN¥173.8B) exceed its short term liabilities (CN¥129.5B).

Passività a lungo termine: 601607's short term assets (CN¥173.8B) exceed its long term liabilities (CN¥11.1B).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 601607's net debt to equity ratio (7.3%) is considered satisfactory.

Riduzione del debito: 601607's debt to equity ratio has reduced from 64.8% to 58.2% over the past 5 years.

Copertura del debito: 601607's debt is not well covered by operating cash flow (11.8%).

Copertura degli interessi: 601607 earns more interest than it pays, so coverage of interest payments is not a concern.


Bilancio


Scoprire le aziende sane